Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2017 Jan 5:3:2.
doi: 10.1038/s41537-016-0001-5. eCollection 2017.

Personalized medicine for schizophrenia

Peter F Buckley  1 , Brian J Miller  1
Affiliations
Editorial

Personalized medicine for schizophrenia

Peter F Buckley et al. NPJ Schizophr. .
No abstract available

PubMed Disclaimer

References

    1. Heres S, et al. Why olanzapine beats risperidone, risperidone beats quetiapine, and quetiapine beats olanzapine: an exploratory analysis of head-to-head comparison studies of second-generation antipsychotics. Am. J. Psychiatry. 2006;163:185–194. doi: 10.1176/appi.ajp.163.2.185. - DOI - PubMed
    1. Lyman GH, Moses HL. Biomarker tests for molecularly targeted therapies – the key to unlocking precision medicine. N. Engl. J. Med. 2016;375:4–6. doi: 10.1056/NEJMp1604033. - DOI - PubMed
    1. Blumenthal GM, Mansfield E, Pazdur R. Next-generation sequencing in oncology in the era of precision medicine. JAMA Oncol. 2016;2:13–14. doi: 10.1001/jamaoncol.2015.4503. - DOI - PubMed
    1. Tannock IF, Hickman JA. Limits to personalized cancer medicine. N. Engl. J. Med. 2016;375:1289–1294. doi: 10.1056/NEJMsb1607705. - DOI - PubMed
    1. Rotanski SK, Marshall RS. Precision medicine for ischemic stroke. JAMA Neurol. 2016;73:773–774. doi: 10.1001/jamaneurol.2016.0087. - DOI - PubMed

Publication types

LinkOut - more resources